Wednesday, 16 October 2019

Drug Discovery News

  • Theravance, Alfa Wassermann collaborate

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in certain countries for velusetrag, Theravance's investigational 5-HT4 agon...Read more

  • Epilepsy Foundation asks DEA to better review process

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process for reviewing new treatments, which currently lack innovation and tra...Read more

  • Fight against TB needs $1.6 bn funding annually

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

    Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at l...Read more

  • Daiichi to aid drug discovery projects

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project for 2013. The company will select research partners for the proj...Read more

  • Queensland to get a new drug development center

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

    Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk announced the establishment of the University of Queensland Emory Drug D...Read more

  • FDA follows EU, declares Patrys drug as 'orphan'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from t...Read more

  • AbbVie, Galapagos to make drugs for cystic fibrosis mutations

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an in...Read more

  • Mylan to produce generic of Gilead's HIV drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top this agreement, Mylan licensed the rights to produce and market generic ...Read more

  • MNCs bet on China to tide over patent cliff

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has etched an important spot for itself in that space in recent times. In ...Read more

  • Anaphore changes corporate name to RuiYi

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of novel biologic therapies in China, including monoclonal antibodies tha...Read more

  • Phylogica gets $400K grant to boost drug discovery

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Council (ARC) to collaborate with scientists at University of Queensland...Read more

  • Daiichi gets positive results in prasugrel trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial comparing efficacy and safety of prasugrel hydrochloride 20 mg loading...Read more

  • AstraZeneca acquires Pearl Therapeutics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood City, California, focused on the development of inhaled small-molecule ...Read more

  • Target for potent first-strike influenza drugs identified

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely target and inhibit an enzyme essential for the influenza virus replic...Read more

  • TaiGen gets TFDA nod for bacterial pneumonia drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 ...Read more

  • Bionomics to raise $16.4 mn for Alzheimer's R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across drug pipeline, including BNC375, Bionomics' drug candidate for the tre...Read more

  • Advinus gets $36 mn research funding from Takeda

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year discovery collaboration. Under the terms of the agreement, Takeda will...Read more

  • Aslan gastric cancer phase II study shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2013

    Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule pan-HER inhibitor, in gastric cancer. Aslan001 reduced cell prolifer...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls